Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.11.1.7 (
peroxidase
)
65,474
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acute reversible lesion in the medial preoptic area (MPOA) by unilateral injection of the local anesthetic lidocaine chlorhydrate (1 microliter, 20 ng/microliters) causes a transient increase in water intake induced by water deprivation in rats. Since lidocaine suppresses the nervous activity, leaving intact fibers of passage and blood vessels, the results suggest an intrinsic inhibitory action of the MPOA on the regulation of water intake. Drinking elicited a return to volumes similar to those of control rats, 3-4 h after lidocaine administration. Lidocaine released into the lateral preoptic area (LPO) slightly decreased or did not change water intake, as compared with controls. The urinary excretion in the
MPO
group was higher than that of the controls and the LPO, while this last group excreted significantly less urine. The ablation of the
POA
with lidocaine suggests that the medial aspect of the
POA
has an intrinsic inhibitory factor influencing drinking, while the lateral aspect did not show a relevant effect.
...
PMID:The involvement of the hypothalamic preoptic area on the regulation of thirst in the rat. 145 40
An enzyme immunoassay for
POA
prepared by Gelder et al. was developed in our laboratory. Elevated serum
POA
levels were shown in 70.6% (36/51) of patients with pancreatic cancer.
POA
levels were related neither to the stage nor to the degree of differentiation of pancreatic cancer. Although
POA
levels were not elevated in patients with benign diseases of the pancreas, they were elevated in patients with cancer of the hepato-biliary tract. In pancreatic cancer patients with pre-operative high
POA
levels, serial
POA
determinations following tumor resection are considered to be useful for detecting recurrence of disease. Employing the unlabeled antibody
peroxidase
-antiperoxidase (PAP) method,
POA
was detected in the cytoplasm of cancer cells in 80.0% (28/35) of pancreatic cancer patients, but not in histologically normal pancreatic tissue. Well differentiated cancer cells showed higher
POA
stainability than less differentiated ones.
POA
was also detected in fetal pancreas tissues of 22 weeks gestation, but not in those of 12-16 weeks gestation. This result suggests that
POA
is an oncofetal antigen.
...
PMID:[Studies on a pancreatic oncofetal antigen (POA) in patients with pancreatic cancer]. 378 34